Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

Boston leads in healthcare M&A

The top city for healthcare mergers and acquisitions is Boston, according to an analysis by Mergermarket and Acuris.

Thumbnail

ACO industry requests more time to apply for CMS program changes

The accountable care organization industry is asking for a later deadline to apply for CMS’ revamped Medicare Shared Savings Program.

Thumbnail

Johns Hopkins hires investigator amid children’s hospital scandal

A former federal prosecutor has been appointed to lead an investigation into the Johns Hopkins All Children’s Hospital heart surgery unit, The Tampa Bay Times reported. The hospital, based in St. Petersburg, Florida, has been the focus of a scandal after a recent Tampa Bay Times investigation revealed the unit’s mortality rate had tripled in just a few years.

Thumbnail

CMS hires new acting Medicaid, CHIP director

Chris Traylor has been named acting director of Medicaid and the Children’s Health Insurance Program (CHIP) after his predecessor, Mary Mayhew, resigned Jan. 4 after just three months on the job.

Thumbnail

Why private equity money targets physician practices

The emergence of private equity funding across physician practices has continued into 2019, with these firms targeting high-value platforms that can turn around a nice profit in a sale just a few years later. The phenomenon has led to a decline in independent physician practices and created new implications for care services, according to an article in the Annals of Internal Medicine.

Thumbnail

Gov. shutdown could delay CVS-Aetna deal proceedings

The $69 billion merger between CVS Health and Aetna is facing another potential obstacle, as the government shutdown could impact court proceedings currently holding up closure of the deal, Reuters reported.

Thumbnail

Trump administration’s assault on drug prices stuck on Twitter

HHS Secretary Alex Azar has a demand for the pharmaceutical industry: “Prices must start coming down.”

Thumbnail

Rising drug costs caused by price hikes, not new innovations

Drug prices are going up not just because of new innovations in medications, as the pharma industry frequently cites, but also because the industry is pricing existing products higher, according to a Health Affairs study.

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.